摘要
目的:探索恶性肿瘤患者自体输血的可行性。方法:分析自体输血和异体输血对择期手术恶性肿瘤患者的影响。结果:肿瘤患者自体输血较异体输血,输血反应发生率、感染率和输血费用低。结论:对恶性肿瘤患者实施自体输血是可行的,既可节约血源又减少输血反应的发生和疾病传播,而且不需要检测血型和交叉配血,减少患者经济负担。
Objective：To investigate the feasibility of autologous transfusion of patients with malignancy tumor.Methods：The effects of autologous transfusion and homologous transfusion on malignancy tumor patients with optional operation were analyzed.Results：Patients received autologous transfusion has lower incidence of transfusion reactions,lower infection rate and lower fare,compared to patients received homologous transfusion.Conclusion：It is feasible to practice autologous transfusion in patients with malignant tumors,which could save the source of blood,decrease transfusion reactions and transfusion transmitted diseases,and need no blood group typing,cross matching and blood cost and reduce the financial burden of patients.
出处
《临床血液学杂志（输血与检验）》
CAS
2010年第2期207-209,共3页
Journal of Clinical Hematology(Blood Transfusion & Laboratory Medicine)
关键词
恶性肿瘤患者
自体输血
输血相关疾病
patients with malignancy tumor
autologous transfusion
transfusion-related diseases
